Back to results
US 12,139,550 B2Granted
Monoclonal antibody against canine fibroblast activation protein that cross-reacts with mouse and human fibroblast activation protein (FAP)
AssigneeThe Trustees of the University of Pennsylvania
InventorsEllen Puré, Leslie Todd
Life of this patent
Estimating the term…
Abstract
The present invention relates to antibodies, binding polypeptides, and scFvs specific for fibroblast activation protein (FAP) capable of cross reacting with canine, mouse, and human FAP.
Claims11
An isolated nucleic acid comprising a nucleic acid sequence encoding an antigen-binding domain that specifically binds to an epitope of a fibroblast activation protein (FAP), wherein the antigen binding domain comprises:
- (a) a heavy chain variable region that comprises a heavy chain complementarity determining region (HCDR) 1 comprising the amino acid sequence YTITSYSLH (SEQ ID NO:
- 1), a HCDR2 comprising the amino acid sequence EINPANGDHNFSEKFEIK (SEQ ID NO:
- 2), and a HCDR3 comprising the amino acid sequence LDDSRFHWYFDV (SEQ ID NO:
- 3);
- and
- (b) a light chain variable region that comprises a light chain complementarity determining region 1 (LCDRs) comprising the amino acid sequence TASSSVSYMY (SEQ ID NO:
- 4), a LCDR2 comprising the amino acid sequence LTSNLA (SEQ ID NO:
- 5), and a LCDR3 comprising the amino acid sequence QQWSGYPPIT (SEQ ID NO:
- 6).
6 more elements
Dependencies are inferred from the claim text.